NEW YORK (GenomeWeb) – The Windber Medical Center (WMC) and Windber Research Institute (WRI) today announced definitive agreements with the Chan Soon-Shiong Institute of Molecular Research Institute to create an integrated healthcare organization.
As part of the agreement, a precision cancer research and treatment institute will be created at WMC and WRI, the Windber facilities said, adding its vision is to make WMC and WRI "dedicated molecular medicine and genomic research institutions and centers of excellence for studying cancer and other diseases."
The Chan Soon-Shiong Institute of Molecular Research Institute is a division of the Chan Soon-Shiong NantHealth Foundation and was founded by Patrick Soon-Shiong and his wife Michele Chan. In a statement Soon-Shiong said that the institute's expertise and resources "combined with WRI's state-of-the-art tissue bank and DNA and RNA extraction capabilities furthers the stated mission of our respective organizations, which is to engage in advanced medical care and pioneering medical research for the benefit of patients."
WRI is a non-profit biomedical research institute and has two programs — translational research and health promotion/disease prevention. WMC is a non-profit community healthcare provider.